Research abstracts Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting? Share Share on Facebook Share on Twitter Publication year 2006 Author(s) Weschules, D. J.; Maxwell, T.; Reifsnyder, J.; Knowlton, C. H. Pages 135-49 Volume 23 Number 2 Share Share on Facebook Share on Twitter Research abstracts
